4
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Regulation of colony-stimulating factor-induced human myelopoiesis by transforming growth factor-β isoforms

, &
Pages 31-36 | Published online: 26 Sep 2009

  • Moses HL, Yang EY, Pietenpol JA, TGF-ß stimulation and inhibition of cell proliferation: new mechanistic insights. Cell (1990) 63: 245-7.
  • Roberts AB, Sporn MB, Physiological actions and clinical applications of transforming growth factor-ß (TGF-ß). Growth Factors (1993) 8: 1-9.
  • Massagué J, The transforming growth factor-ß family. Annu Rev Cell Biol (1990) 6: 597-641.
  • Massagué J, TGF-ß signal transduction. Annu Rev Biochem (1998) 67:753-91.
  • Markowitz S, Wang J, Myeroff I. et al, Inacitvation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science (1995) 268: 1336-8.
  • Thiagalingam S, Lengauer C, Leach FS et al, Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 13: 343-6.
  • Takagi Y, Kohmura H, Futamura M et al, Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology (1996) 111: 1387-9.
  • McGrogan D, Pegram M, Slamon D, Bookstein R. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene (1997) 15: 1111-14.
  • Hahn SA, Hoque ATMS, Moskaluk CA et al, Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res (1996) 56: 490-4.
  • Wang D, Song H, Evans JA et al, Mutation and down regulation of the transforming growth factor-ß type II receptor gene in primary squamous cell carcinomas of the head and neck, Carcinogenesis (1997) 18: 2285-90.
  • Grady WM, Rajput A, Myeroff L et al, Mutation of the type II transforming growth factor-ß receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res (1998) 58: 3101-4.
  • Isaka Y, Brees DK, Ikegaya K et al, Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 2: 418-23.
  • Khalil N, Greenberg AH, The role of TGF-ß in pulmonary' fibrosis. Ciba Found Symp (1991) 157: 194-207.
  • Castilla A, Prieto J, Fausto N. Transforming growth factors ßl and a in chronic liver disease Effects of interferon alpha therapy. N Engl J Med (1991) 324: 933-40.
  • Peltonen J, Hsiao LL, Jaakkola S et al, Activation of collagen gene expression in keloids: co-localization of type 1 and VI collagen and transforming growth factor-ß1 mRNA. J Invest Dermatol (1991) 97: 240-8.
  • Giri SN, Hyde DM, Hollinger MA, Effect of antibody to transforming growth factor-ß on bleomycin induced accumulation of lung collagen in mice. Thorax (1993) 48: 959-66.
  • Roberts AB, Sporn MB, Physiological actions and clinical applications of transforming growth factor-ß fTGF-ß). Growth Factors (1993) 8: 1-9.
  • Suardet L, Gaide AC, Calmes JM et al, Responsiveness of three newly established human colorectat cancer cell lines to transforming growth factors ßl and ß2. Cancer Res (1992) 52: 3705-12.
  • Cheifetz S, Weatherbee JA, Tsang MLS et al, The transforming growth factor-ß system, a complex pattern of cross-reactive ligands and receptors. Cell (1987) 48: 409-15.
  • Cheifetz S, Bellon T, Calés C et al, Endoglin is a component of the transforming growth factor-ß receptor system in human endothelial cells. J Biol Chem (1992) 267: 19027-30.
  • Cheifetz S, Massagué J, Isoform-specific transforming growth factor-ß binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J Biol Chem (1991) 266: 20767-72.
  • Morello JP, Plamondon J, Meyrick B et al, Transforming growth factor-ß receptor expression on endothelial cells: Heterogeneity of type III receptor expression. J Cell Physiol (1995) 165: 201-11.
  • Dumont N, O'Connor-McCourt MD, Philip A, Transforming growth factor-ß receptors on human endometrial cells: identification of the type I, II, and III receptors and glycosylphosphatidylinositol anchored TGF-ß binding proteins. Mol Cell Endocrinol (1995) 111: 57-66.
  • O'Connor-McCourt M, Wakefield LM, Latent transforming growth factor beta in serum. A specific complex with ß2macroglobulin. J Biol Chem (1987) 262: 14090-99.
  • Crookston KP, Webb DJ, Wolf BB, Gonias SL. Classification of ß2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions, J Biol Chem (1994) 269: 1533-40.
  • Burmester JK, Qian SW, Ohlsen D et al, Mutational analysis of a transforming growth factor-ß receptor binding site. Growth Factors (1998) 15: 231-42.
  • Qian SW, Burmester JK, Tsang MLS et al, Binding affinity of transforming growth factor-ß to the type II receptor is determined by the C-terminal region of the molecule. J Biol Chem (1996) 271: 30656-62.
  • Qian SW, Dumont N, O'Connor-McCourt M, Burmester JK, Distinct functional domains of TGF-ß bind receptors on endothelial cells. Growth Factors (1999) 17: 63-73.
  • Jacobsen SEW, Keller JR, Ruscett FW et al, Bidirectional effects of transforming growth factor-ß (TGF-ß) on colony-stimulating factor-induced human myelopoiesis in vitro. Differential effects of distinct TGF-ß isoforms. Blood (1991) 78: 2239-47.
  • Jacobsen SEW, Ruscetti FW, Roberts AB, Keller JR, TGF-ß is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-ßl and TGF-ß31. J Immunol (1993) 151: 4534-44.
  • Archer SJ, Bax A, Roberts AB et al, Transforming growth factorß1: NMR signal assignments of the recombinant protein expressed and isotopically enriched using Chinese hamster ovary cells. Biocliemistry (1993) 32: 1152-63.
  • Hinck AP, Archer SJ, Qian SW et al, Transforming growth factor ßl: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor ß2. Biochemistry (1996) 35: 8517-34.
  • Danielpour D, Dan LL, Flanders KC et al, Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-ßl and TGF-ß2) secreted by cells in culture. J Cell Physiol (1989) 138: 79-86.
  • Burmester JK, Qian SW, Roberts AB et al, Characterization of distinct functional domains of transforming growth factor-ß. Proc Natl Acad Sci USA (1993) 90: 8628-32.
  • Ottmann OG, Pelus LM, Differential proliferative effects of transforming growth factor-ß on human hematopoietic progenitor cells. J Immunol (1998) 140: 2661-5.
  • Ohta M, Greenberger JS, Anklesaria P et al, Two forms of transforming growth factor-ß distinguished by multipotential haematopoietic progenitor cells. Nature (1987) 329: 539-41.
  • Wahl S, Hunt D, Wakefield LM et al, Transforming growth factor type-ß induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA (1987) 84: 5788-92.
  • Ruscetti FW, Dubois CM, Jacobsen SEW, Keller JR, Transforming growth factor-ß and interleukin-1: a paradigm for opposing regulation of haemopoiesis. Baillieres Clin Haematol (1992) 5:703-21.
  • Grzegnzewski K, Ruscerri FW, Usui N et al. Recombinant transforming growth factor-ß 1 and ß2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. Exp Med (1994) 180: 1047-57.
  • Lemoli RM, Strife A, Clarkson BD et al, TGF-ß3 protects normal human hematopoietic cells treated with 4-hydroperoxyclophosphamide in vitro. Exp Haematol (1992) 20: 1251-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.